Health care stocks were flat to lower premarket Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was recently down 0.3%.
ImmunoPrecise Antibodies (IPA) shares rallied past 14% after the company announced a strategic partnership with an unnamed biotechnology company to discover and develop antibody-drug conjugates and bispecific antibodies to treat cancer.
Integer Holdings (ITGR) shares were down nearly 2% amid plans to offer $750 million of convertible notes due 2030.
Tarsus Pharmaceuticals (TARS) shares were almost 3% lower after the company priced an upsized underwritten public offering of 2.8 million shares at $44.50 per share for gross proceeds of about $125 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。